1
|
Toso A, Arazi A, Braun A, Marin R, Poletaeva A, Sterzer P, De La Rocha J, Donner T. P-13 Shaping perceptual decision formation by GABA-A and NMDA receptor manipulation. Clin Neurophysiol 2023. [DOI: 10.1016/j.clinph.2023.02.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/08/2023]
|
2
|
Marinelli C, Zingone F, Lupo MG, Marin R, D’Incà R, Gubbiotti A, Massimi D, Casadei C, Barberio B, Ferri N, Savarino E. Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study. J Clin Gastroenterol 2022; 56:787-793. [PMID: 34560758 PMCID: PMC9988229 DOI: 10.1097/mcg.0000000000001607] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/31/2021] [Accepted: 07/24/2021] [Indexed: 01/07/2023]
Abstract
BACKGROUND/GOAL Ulcerative colitis (UC) is characterized by chronic inflammation and progressive course, with potential extraintestinal complications including cardiovascular mortality. Serum proprotein convertase subtilisin/kexin type 9 (PCSK9) levels have been recently recognized as biomarkers of low-grade inflammation and cardiovascular disease. The aim of our study was to evaluate PCSK9 levels in patients with UC and different degrees of disease activity. METHODS We prospectively recruited consecutive patients with UC attending our center at the University Hospital of Padua. Demographics, clinical characteristics, and biochemical data, including PCSK9, high sensitivity C-reactive protein, and fecal calprotectin, were recorded. Moreover, endoscopic procedures were performed in all subjects. RESULTS We included 112 patients with UC (mean age=52.62±12.84 y; 52.62% males). Patients with UC and abnormal fecal calprotectin (≥250 µg/g) and/or C-reactive protein (≥3 mg/L) had greater levels of PCSK9 compared with UC patients with normal fecal calprotectin and high sensitivity C-reactive protein ( P =0.03 and 0.005, respectively). Higher endoscopic scores in UC were characterized by greater levels of PCSK9 ( P =0.03). Furthermore, we found a positive correlation between PCSK9 levels and fecal calprotectin ( r =0.18, P =0.04), endoscopic Mayo Score ( r =0.25, P =0.007), and UC-Riley Index ( r =0.22, P =0.01). We also found a positive correlation between PCSK9 levels and both total and low-density lipoprotein cholesterol values ( P <0.05). CONCLUSIONS Serum PCSK9 levels are increased in patients with biochemical and endoscopic evidence of active disease in UC. Further longitudinal studies are necessary to evaluate the role of PCSK9 as a potential biomarker of disease activity and cardiovascular risk in UC.
Collapse
Affiliation(s)
- Carla Marinelli
- Gastroenterology Section, Departments of Surgery, Oncology, and Gastroenterology
| | - Fabiana Zingone
- Gastroenterology Section, Departments of Surgery, Oncology, and Gastroenterology
| | | | | | - Renata D’Incà
- Gastroenterology Section, Departments of Surgery, Oncology, and Gastroenterology
| | - Alessandro Gubbiotti
- Gastroenterology Section, Departments of Surgery, Oncology, and Gastroenterology
| | - Davide Massimi
- Gastroenterology Section, Departments of Surgery, Oncology, and Gastroenterology
| | - Cesare Casadei
- Gastroenterology Section, Departments of Surgery, Oncology, and Gastroenterology
| | - Brigida Barberio
- Gastroenterology Section, Departments of Surgery, Oncology, and Gastroenterology
| | | | - Edoardo Savarino
- Gastroenterology Section, Departments of Surgery, Oncology, and Gastroenterology
| |
Collapse
|
3
|
Palermi S, Brugin E, Compagno S, Pescatore V, Tegon G, Gerbino L, Sarto M, Marin R, Volpato R, Masato M, Panico A, Biffi A, Giada F. P372 PATIENTS WITH MINOR NON–DISABLING STROKE (MINDS): RESULTS OF A STRUCTURED CARDIOVASCULAR REHABILITATION PROGRAM. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartj/suac012.358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Background
Ischemic cerebral and cardiac events are the leading causes of mortality and morbidity in Minor non–Disabling Stroke (MiNDS) patients. Control of cardiovascular risk factors, including physical activity levels, is a key strategy in secondary prevention of MiNDS. However, there is a gap between recommendations and real achieved physical activity levels in these patients. Clinical benefits obtained with cardiovascular rehabilitation in cardiac ischemic patients could be obtained with similar programs also in patients with MiNDS, given the common pathophysiological substrate of these two diseases Purpose To evaluate safety, effectiveness and feasibility of a cardiovascular rehabilitation program based on structured physical exercise (SPE) in patients with MiNDS
Methods
39 MiNDS patients (26 males, mean age 66 years) underwent an accurate medical screening process, body composition evaluation, cardiopulmonary exercise test (CPET) and muscular strength assessment, before and after a 12–sessions in–hospital SPE program, and after 6– and 12–months follow–up during which they could continue their training schedule on their own Results After in–hospital rehabilitation program, a significant improvement in CPET parameters, body composition and muscular strength was observed. These modifications persisted in the 32 patients who continued 6– and 12– months follow–up training, while regressed in the 7 patients who stopped training
Conclusions - Results
of the present study show that a SPE–based cardiovascular rehabilitation program provides clinical benefit in patients with MiNDS
Collapse
Affiliation(s)
- S Palermi
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - E Brugin
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - S Compagno
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - V Pescatore
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - G Tegon
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - L Gerbino
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - M Sarto
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - R Marin
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - R Volpato
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - M Masato
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - A Panico
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - A Biffi
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - F Giada
- DIPARTIMENTO DI SANITÀ PUBBLICA – UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE – VENEZIA, NOALE; UOC NEUROLOGIA, OSPEDALE DI DOLO, DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| |
Collapse
|
4
|
Compagno S, Palermi S, Pescatore V, Brugin E, Tegon G, Sarto M, Marin R, Calzavara V, Nizzetto M, Scevola M, Albertin C, Biffi A, Giada F. P368 PHYSICAL AND PSYCHOLOGICAL RECONDITIONING IN LONG COVID SYNDROME: RESULTS OF AN OUT–OF–HOSPITAL EXERCISED–BASED CARDIOVASCULAR REHABILITATION PROGRAM. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartj/suac012.354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Background
Long Covid Syndrome (LCS) is used to describe signs and symptoms that continue or develop after acute COVID–19 infection. Natural history and treatments of this syndrome are still poorly understood, even if evidence suggests the potential role of physical rehabilitation in improving symptoms in these subjects.
Aim
The aim of the present study was to evaluate safety, effectiveness and feasibility of a multidisciplinary, out–of–hospital, exercise–based cardiac rehabilitation (EBCR) program, of two months duration, in improving symptoms and physical and psychological parameters in patients with LCS Methods Thirty consecutive patients with LCS (18 males, mean age 58 years) underwent an accurate medical screening process including anthropometric and muscular strength evaluation, cardiopulmonary exercise test (CPET), quality of life (QoL) and psychological appraisal before and after an EBCR program.
Results
At baseline, all LCS patients were strongly symptomatic and showed severe impairments in physical performance, QoL and psychological parameters. No adverse effects and dropouts were observed during the exercise training sessions. After the EBCR program, COVID–19 residual symptoms significantly decreased and significant improvements in upper and lower limb muscular strength, CPET parameters, perceived physical and mental health, depression and anxiety were observed.
Conclusions
The present study confirms the severe physical and psychological impairment of patients with LCS and suggests that a multidisciplinary EBCR program could promote their physical and psychological recovery
Collapse
Affiliation(s)
- S Compagno
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - S Palermi
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - V Pescatore
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - E Brugin
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - G Tegon
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - M Sarto
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - R Marin
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - V Calzavara
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - M Nizzetto
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - M Scevola
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - C Albertin
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - A Biffi
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| | - F Giada
- UOC MEDICINA DELLO SPORT E CARDIOLOGIA RIABILITATIVA, OSPEDALE PF CALVI, NOALE–VENEZIA, NOALE; DIPARTIMENTO DI SANITÀ PUBBLICA, UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, NAPOLI; UOC DI PNEUMOLOGIA, OSPEDALE DI DOLO, DOLO; UOC DI MEDICINA INTERNA, OSPEDALE DI DOLO, DOLO; UOC DI FISIATRIA, OSPEDALE DI DOLO, DOLO; MED–EX, MEDICINE & EXERCISE, MEDICAL PARTNER DELLA SCUDERIA FERRARI, ROMA
| |
Collapse
|
5
|
Palermi S, Brugin E, Compagno S, Pescatore V, Tegon G, Sarto M, Marin R, Masato M, Panico A, Biffi A, Giada F. Patients with Minor Non-Disabling Stroke (MiNDS): results of a structured cardiovascular rehabilitation program. Eur J Prev Cardiol 2022. [DOI: 10.1093/eurjpc/zwac056.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Ischemic cerebral and cardiac events are the leading causes of mortality and morbidity in Minor non-Disabling Stroke (MiNDS) patients. Control of cardiovascular risk factors, including physical activity levels, is a key strategy in secondary prevention of MiNDS. However, there is a gap between recommendations and real achieved physical activity levels in these patients. Clinical benefits obtained with cardiovascular rehabilitation in cardiac ischemic patients could be obtained with similar programs also in patients with MiNDS, given the common pathophysiological substrate of these two diseases.
Purpose
To evaluate safety, effectiveness and feasibility of a cardiovascular rehabilitation program based on structured physical exercise (SPE) in patients with MiNDS.
Methods
39 MiNDS patients (26 males, mean age 66 years) underwent an accurate medical screening process, body composition evaluation, cardiopulmonary exercise test (CPET) and muscular strength assessment, before and after a 12-sessions in-hospital SPE program, and after 6- and 12-months follow-up during which they could continue their training schedule on their own.
Results
After in-hospital rehabilitation program, a significant improvement in CPET parameters, body composition and muscular strength was observed. These modifications persisted in the 32 patients who continued 6- and 12- months follow-up training, while regressed in the 7 patients who stopped training.
Conclusions
Results of the present study show that a SPE-based cardiovascular rehabilitation program provides clinical benefit in patients with MiNDS.
Collapse
Affiliation(s)
- S Palermi
- Federico II University Hospital, Naples, Italy
| | - E Brugin
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - S Compagno
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - V Pescatore
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - G Tegon
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - M Sarto
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - R Marin
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | | | | | - A Biffi
- Med-Ex, Medicine & Exercise, Medical Partner Scuderia Ferrari, Rome, Italy
| | - F Giada
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| |
Collapse
|
6
|
Palermi S, Compagno S, Pescatore V, Brugin E, Tegon G, Sarto M, Marin R, Calzavara V, Nizzetto M, Scevola M, Albertin C, Biffi A, Giada F. Physical and psychological reconditioning in long covid syndrome patients: results of a structured physical exercise program. Eur J Prev Cardiol 2022. [PMCID: PMC9383996 DOI: 10.1093/eurjpc/zwac056.218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Funding Acknowledgements Type of funding sources: None. Background Long Covid Syndrome (LCS) is used to describe signs and symptoms that continue or develop after acute COVID-19 infection. Natural history and treatments of this syndrome is still poorly understood. In literature there is currently a lack of data on the real effectiveness of a multidisciplinary rehabilitation program based on structured physical exercise (SPE) in these patients. Purpose To evaluate safety, effectiveness and feasibility of a structured individualized rehabilitation program in improving physical and psychological parameters in patients with LCS. Methods Twenty-eight patients with LCS (19 males, mean age 57 years) underwent an accurate medical screening process, body composition evaluation, cardiopulmonary exercise test (CPET), muscular strength assessment, quality of life (QoL), psychological assessment and counselling, before and after a 12-sessions SPE program. Results At baseline, all LCS patients showed severe impairments in physical performance, QoL and psychological parameters. No adverse effects and dropouts were observed during training session. After the rehabilitation program, significant improvement in CPET parameters, upper and lower limb muscular strength, perceived physical and mental health, body composition, depression and anxiety and Covid residual symptoms was observed. Conclusions The present study confirms severe impairment of patients with LCS and suggest that a multidisciplinary rehabilitation program based on SPE could promote their physical and psychological recovery.
Collapse
Affiliation(s)
- S Palermi
- Federico II University Hospital, Naples, Italy
| | - S Compagno
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - V Pescatore
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - E Brugin
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - G Tegon
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - M Sarto
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - R Marin
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - V Calzavara
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| | - M Nizzetto
- Sub-Intensive Care COVID Unit in Pneumology, Dolo, Italy
| | - M Scevola
- Non-critical COVID Area in Internal Medicine, Dolo, Italy
| | - C Albertin
- Physical Medicine & Rehabilitation service, Dolo, Italy
| | - A Biffi
- Med-Ex, Medicine & Exercise, Medical Partner Scuderia Ferrari, Rome, Italy
| | - F Giada
- Noale Hospital, Cardiovascular Rehabilitation and Sports Medicine Service, Cardiovascular Department, Noale, Italy
| |
Collapse
|
7
|
Chen Z, Bertin R, Marin R, Medjiofack Djeujo F, Froldi G. Effects of Croton lechleri sap (Sangre de Drago) on AGEs formation, LDL oxidation and oxidative stress related to vascular diseases. Nat Prod Res 2021; 36:4165-4169. [PMID: 34338088 DOI: 10.1080/14786419.2021.1960520] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
The sap of Croton lechleri Müll. Arg. (Euphorbiaceae) is well-known in South American traditional medicine. This research investigated its activity against glycation and oxidative stress (glycoxidation) to estimate its usefulness in ROS-related diseases. The activity of the sap on albumin glycation, LDL oxidation and ROS formation was detected. C. lechleri sap inhibited BSA glycation and exhibited a protective effect against LDL oxidation; at the concentration of 0.8 µg/mL, it extended the Lag phase of almost 60%. Furthermore, the sap was studied on cell viability and ROS production in HUVEC showing valuable free-radical scavenging activity. In detail, the sap (1.0 and 10.0 μg/mL) significantly decreased the baseline level and H2O2-induced ROS production in HUVEC. This research showed for the first time the ability of C. lechleri sap to decrease the albumin glycation, LDL oxidation and ROS formation in HUVEC, supporting its potential in vascular diseases.
Collapse
Affiliation(s)
- Zheng Chen
- Department of Pharmaceutical and Pharmacological Sciences (DSF), University of Padova, Padova, Italy
| | - Riccardo Bertin
- Department of Pharmaceutical and Pharmacological Sciences (DSF), University of Padova, Padova, Italy
| | - Raffaella Marin
- Department of Medicine (DIMED), University of Padova, Padova, Italy
| | | | - Guglielmina Froldi
- Department of Pharmaceutical and Pharmacological Sciences (DSF), University of Padova, Padova, Italy
| |
Collapse
|
8
|
Alcoberro L, Vime J, Enjuanes C, Jimenez S, Garay A, Yun S, Moliner P, Guerrero C, Hidalgo E, Calero E, Marin R, Alcober L, Delso C, Comin J. Double check discharge planning to improve the results of a heart failure programme. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Reduction of readmissions in heart failure (HF) patients is a main goal of HF programmes. Establishing a discharge planning for the patient and coordinating it with primary care teams are key aspects for their success.
Purpose
Evaluate whether a double check discharge planning based on adding face-to-face joint weekly sessions with primary care managers to the conventional electronic communication of care plan reduces 6-month readmission and 6-month mortality.
Methods
We evaluated all patients discharged from hospital with HF as primary diagnosis between September 2017 and January 2019. We compared outcomes between patients discharged during Period #1 (single check; September 2017 - April 2018) and those discharged during Period #2 (double check; May 2018 - January 2019).
Primary endpoint was the combined endpoint of all-cause death or all-cause hospitalization 6 months after discharge from the index hospitalization.
Results
The study enrolled 317 patients: 182 in Period #1 and 135 in Period #2.
Mean age was 76±9 years. There was a higher proportion of patients with diabetes and COPD in Period #1, with no differences in other baseline characteristics.
The combined endpoint of all cause-death and all-cause hospitalization at 6 months was significantly reduced in patients in the double check discharge planning group (27% vs. 16%, p 0.021).
Conclusions
In a HF programme, the addition of a double check discharge planning based on having joint weekly sessions with primary care managers on top of the conventional electronic communication of care plan reduces 6-month readmission and 6-month mortality.
Funding Acknowledgement
Type of funding source: Public hospital(s). Main funding source(s): Hospital Universitari de Bellvitge
Collapse
Affiliation(s)
- L Alcoberro
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - J Vime
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - C Enjuanes
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - S Jimenez
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - A Garay
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - S Yun
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - P Moliner
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - C Guerrero
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - E Hidalgo
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - E Calero
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - R Marin
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - L Alcober
- Delta Primary Care Service, ICS, Hospitalet de Llobregat, Spain
| | - C Delso
- Delta Primary Care Service, ICS, Hospitalet de Llobregat, Spain
| | - J Comin
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| |
Collapse
|
9
|
Guerrero G, Alcoberro L, Vime J, Calero E, Hidalgo E, Marin R, Enjuanes C, Garay A, Yun S, Jimenez S, Moliner P, Delso C, Fernandez I, Rosenfeld L, Comin J. Effectiveness of nurse-led hospital-based heart failure programmes in octagenarians and nonagenarians: is age important? Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Efficacy of HF programmes in oldest old (octogenarians and nonagenarians) has not been fully explored.
Methods
We conducted a natural experiment evaluating all patients after hospitalization for heart failure as primary diagnosis between January 2017 and January 2019. We compared outcomes between patients discharged during Period #1, before the implementation of the program with patients discharged during Period #2, after the implementation of the 7-step bundle of interventions. We explored the interaction between age group (<80 vs. ≥80 years old) by the intervention modality (HF programme vs. usual care). Primary end-point was the combined end-point of all-cause death or all-cause hospitalization at 6 months after discharge from the index hospitalization.
Results
The study enroled 440 patients. Mean age of the whole cohort was 75±9 years. In the oldest old subgroup (n=160), mean age was 84±3. No differences were found in baseline characteristics of patients between usual care and HF program. 30-day all-cause readmission was significantly reduced in patients in the HF programme group compared to patients in the usual care group in both age strata. In unadjusted Cox regression analyses in the oldest old group, management of patients in the HF programme was significanty associated with a reduction in the risk of the primary end-point (HR: 0.50; 95% CI [0.29–0.85]; p=0.011).
Conclusions
Management of patients in a nurse-led integrated care-based heart failure programme results in reduction of all-cause death or all-cause hospitalizations in oldest old patients.
Event-free survival cumulative curves.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- G Guerrero
- University Hospital Bellvitge, Barcelona, Spain
| | - L Alcoberro
- University Hospital Bellvitge, Barcelona, Spain
| | - J Vime
- University Hospital Bellvitge, Barcelona, Spain
| | - E Calero
- University Hospital Bellvitge, Barcelona, Spain
| | - E Hidalgo
- University Hospital Bellvitge, Barcelona, Spain
| | - R Marin
- University Hospital Bellvitge, Barcelona, Spain
| | - C Enjuanes
- University Hospital Bellvitge, Barcelona, Spain
| | - A Garay
- University Hospital Bellvitge, Barcelona, Spain
| | - S Yun
- University Hospital Bellvitge, Barcelona, Spain
| | - S Jimenez
- University Hospital Bellvitge, Barcelona, Spain
| | - P Moliner
- University Hospital Bellvitge, Barcelona, Spain
| | - C Delso
- University Hospital Bellvitge, Barcelona, Spain
| | - I Fernandez
- University Hospital Bellvitge, Barcelona, Spain
| | - L Rosenfeld
- University Hospital Bellvitge, Barcelona, Spain
| | - J Comin
- University Hospital Bellvitge, Barcelona, Spain
| |
Collapse
|
10
|
Jimenez S, Cainzos-Achirica M, Monterde D, Garcia-Eroles L, Enjuanes C, Garay A, Yun S, Moliner P, Alcoberro L, Calero E, Hidalgo E, Marin R, Corbella X, Comin-Colet J. Epidemiology of potassium derangements among chronic cardiovascular, metabolic and renal conditions: a population-based analysis data from more than 375,000 individuals. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
In patients with chronic cardiovascular, metabolic and renal disorders, potassium (K)+ homeostasis is often delicate, especially in the presence of renin-angiotensin-aldosterone system inhibition (RAASI) and/or diuretic therapies. In this context, current clinical practical guidelines for the management of these patients recommend close monitoring of renal function and K+ levels, particularly in the presence of drug titration. Nevertheless, very limited epidemiological data on their importance at a population level is available.
Purpose
The objectives of the present analysis are to estimate the prevalence of potassium (K+) derangements in five key chronic cardiovascular, metabolic and renal conditions at the population level, its use of RAASI medication and describe potassium derangements among RAASI users.
Methods
We used data from more than 375,000 individuals 55 years of age or older included in the population-based healthcare database of a public Institute of Health between 2015 and 2017. The conditions of interest were chronic heart failure (CHF), chronic kidney disease (CKD), diabetes mellitus (DM), ischemic heart disease (IHD), and hypertension (HTN). RAASI medications included angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, mineralocorticoid receptor antagonists (MRAs), and rennin inhibitors. Hyperkalemia was defined as K+ levels >5.0 mEq/L and hypokalemia as K+ <3.5 mEq /L
Results
The prevalence of chronic cardiovascular, metabolic and renal conditions was high, particularly of HTN (48.2–48.9%). The prevalence of hyperkalemia was ranging between 10% and 25% depending of the condition, more frequent in CKD and less frequent in HTN patients. In figure, we display the prevalence of hyperkalemia among individuals with each of the relevant chronic conditions, January 1st, 2016 and January 1st, 2017. Use of at least one RAASI medication was very prevalent in HTN patients (75.2–77.3%). Among RAASI users, the frequency of K+ derangements and mainly of hyperkalemia was very noticeable (12% overall), especially in patients with CKD, CHF, elderly individuals, and users of MRAs. Hypokalemia was less frequent (1%).
Conclusion
The high prevalence of K+ derangements and predominantly hyperkalemia among RAASI users highlights the real-world relevance of K+ derangements and the importance of close monitoring and management of K+ levels in routine clinical practice. This is likely to benefit a large number of patients, particularly those at higher risk.
Figure 1. Prevalence of hyperkalemia
Funding Acknowledgement
Type of funding source: Private grant(s) and/or Sponsorship. Main funding source(s): Josep Comin-Colet and Miguel Cainzos-Achirica have participated in other research projects funded by unrestricted grants from Vifor Pharma
Collapse
Affiliation(s)
- S Jimenez
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - M Cainzos-Achirica
- Johns Hopkins University of Baltimore, Baltimore, United States of America
| | | | | | - C Enjuanes
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - A Garay
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - S Yun
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - P Moliner
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - L Alcoberro
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - E Calero
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - E Hidalgo
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - R Marin
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - X Corbella
- University Hospital of Bellvitge, Internal Medicine, Barcelona, Spain
| | - J Comin-Colet
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| |
Collapse
|
11
|
Calero E, Hidalgo E, Marin R, Rosenfeld L, Fernandez I, Garay A, Alcoberro L, Jimenez S, Yun S, Guerrero C, Moliner P, Delso C, Alcober L, Enjuanes C, Comin-Colet J. Association between self-care and prognosis in 1123 patients with chronic heart failure. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Self-care is a crucial factor in the education of patients with heart failure (HF) and directly impacts in the progression of the disease. However, little is published about its major clinical implications as admission or mortality in patients with HF.
Aims and methods
The aim of the study was to analyze time to admission due to acute heart failure and mortality associated with poor self-care in patients with chronic HF.
We prospectively recruited consecutive patients with stable chronic HF referred to a nurse-led HF programme. Selfcare was evaluated at baseline with the 9 item European Heart Failure Self-Care Behavior Scale. Scores were standardized and reversed from 0 (worst selfcare) to 100 (better self care). For the purpose of this study we analyzed the associations of worse self-care (defined as scores below the lower tertile of the scale) with demographic, disease-related (clinical) and psychosocial factors in all patients at baseline.
Results
We included 1123 patients, mean age 72±11, 639 (60%) were male, mean LVEF 45±17 and 454 (40,4%) were in NYHA class III or IV. Mean score of the 9-item ESCBE was 69±28. Score below 55 (lower tertile) defined impaired selfcare behaviour.
Those patients with worse self-care had more ischaemic heart disease, more COPD, and they achieved less distance in the 6 minute walking test. Regarding psychosocial items patients in lower tertile of self-care needed a caregiver more frequently, they present more cognitive impairment, depressive symptoms and worse score in terms of health self-perception.
Multivariate Cox Models showed that a score below 55 points in 9-item ESCBE was independently associated with higher readmission due to acute heart failure [HR 1.26 (1.02–1.57), p value=0.034] and with mortality [HR 1.24 CI95% (1.02–1.50), p value=0.028]
Conclusion
Poor self-care measured with the modified 9-item ESCBE was associated with higher risk of admission due to acute decompensation and higher risk of mortality in patients with chronic heart failure.
These results highlight the importance of assessing self-care and provide measures to improve them.
Funding Acknowledgement
Type of funding source: Public hospital(s). Main funding source(s): Hospital Univesitario de Bellvitge
Collapse
Affiliation(s)
- E Calero
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - E Hidalgo
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - R Marin
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - L Rosenfeld
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - I Fernandez
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - A Garay
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - L Alcoberro
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - S Jimenez
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - S Yun
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - C Guerrero
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - P Moliner
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | - C Delso
- Institut Catala de la Salut, Barcelona, Spain
| | - L Alcober
- Primary Care Centre Just Oliveres, Hospitalet De Llobregat, Spain
| | - C Enjuanes
- Primary Care Centre Just Oliveres, Hospitalet De Llobregat, Spain
| | - J Comin-Colet
- Primary Care Centre Just Oliveres, Hospitalet De Llobregat, Spain
| |
Collapse
|
12
|
Jimenez S, Cainzos-Achirica M, Monterde D, Garcia-Eroles L, Enjuanes C, Garay A, Yun S, Alcoberro L, Moliner P, Hidalgo E, Calero E, Marin R, Corbella X, Comin-Colet J. A population-based analysis in 375,233 cases of heart failure stages A, B and C. Real world epidemiology of prevalence and temporal trends in South-European populations. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Prevalence of congestive heart failure (CHF) and predisposing conditions has described previously. Most of these studies evaluated centre-European or north-American populations. However, the prevalence and evolutionary changes of Heart Failure stages A, B and C has not been fully elucidated in Mediterranean cohorts.
Purpose
To estimate the prevalence of CHF (HF Stage C) and four additional key chronic cardiovascular, metabolic and renal conditions predisposing to the development of CHF (HF Stages A and B) at a population level in a south-European healthcare area. We analysed the evolutionary changes in the prevalence in these five conditions.
Methods
In a healthcare area of 1,3Millions inhabitants, we extracted health related information of all individuals ≥55 years old. We analysed data of 375,233 individuals included in the population-based healthcare database of a public Institute of Health between 2015 and 2017. The conditions of interest were CHF, chronic kidney disease (CKD), diabetes mellitus (DM), ischemic heart disease (IHD) and hypertension (HTN).
Results
The prevalence of chronic conditions was high, particularly of HTN (48.2–48.9%) and DM individuals (14.6–14.8%). The other conditions were less frequent, with prevalence around 2–4% for IHD, 5–9% for CKD and 2–4% for CHF (Table). However, the less frequent conditions had a striking upward trend with over 1,500 new prevalent cases per year between 2015 and 2017 for CHF (45% relative increase), more than 2,500 new prevalent cases for IHD (67% relative increase) and more than 4,000 new prevalent cases per year for CKD (44% relative increase).
Conclusion
In this south European cohort, there were a high prevalence of HTN and DM as risk factors and a significant trend of increasing prevalence in high cost chronic conditions such as CHF, IHD and CKD.
Funding Acknowledgement
Type of funding source: Private company. Main funding source(s): The present study was funded by an unrestricted research grant from Vifor Pharma.
Collapse
Affiliation(s)
- S Jimenez
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - M Cainzos-Achirica
- Johns Hopkins University of Baltimore, Baltimore, United States of America
| | | | | | - C Enjuanes
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - A Garay
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - S Yun
- University Hospital of Bellvitge, Internal Medicine, Barcelona, Spain
| | - L Alcoberro
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - P Moliner
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - E Hidalgo
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - E Calero
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - R Marin
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| | - X Corbella
- University Hospital of Bellvitge, Internal Medicine, Barcelona, Spain
| | - J Comin-Colet
- University Hospital of Bellvitge, Cardiology, Barcelona, Spain
| |
Collapse
|
13
|
Alcoberro L, Vime J, Enjuanes C, Jimenez S, Garay A, Yun S, Moliner P, Guerrero C, Hidalgo C, Calero E, Marin R, Alcober L, Delso C, Comin J. Long-term effectiveness of a nurse-led 7-step transitional intervention programme in heart failure. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Reduction of 30-day readmission in heart failure (HF) patients is a main goal of health-care systems. Programmes to decrease 30-day readmission have successfully reduced it but have failed to neither maintain benefit afterwards nor decrease mortality. Moreover, in many cases the price of reducing 30-day readmission is a mortality increase.
Purpose
Evaluate whether the impact of a fully nurse-led HF programme directed to reduce 30-day readmission and mortality extends to longer periods of time, including 90 days and 180 days after discharge.
Methods
We evaluated all patients discharged from hospital with HF as primary diagnosis between January 2017 and January 2019. We compared outcomes between patients discharged during Period #1 (pre-programme; Jan 2017 - Aug 2017) and those discharged during Period #2 (HF programme; Sept 2017 - Jan 2019).
Primary endpoint was the combined endpoint of all-cause death or all-cause hospitalization 90 days and 180 days after discharge from the index hospitalization.
Results
The study enrolled 440 patients: 123 in Period #1 and 317 in Period #2.
Mean age was 75±9 years. There was a higher proportion of female patients in Period #2 (38.2% vs 26.8%, p=0.025), with no differences in other baseline characteristics.
The combined endpoint of all cause-death and all-cause hospitalization was significantly reduced in patients in the HF programme group, both at 90 days [OR 0.37 (0.22–0.63), p<0.001] and at 180 days [OR 0.27 (CI 0.17–0.43), p<0.001]. Such a decrease was at expense of a reduction in cardiovascular (CV) hospitalization and HF hospitalization.
There were no differences between groups in mortality [OR 0.96 (0.18–5.00), p=0.293].
Conclusions
A fully nurse-led HF programme reduces the combined endpoint of all-cause death and all-cause hospitalization both at 90 days and 180 days after an index discharge for HF.
Such a decrease is driven by a reduction of CV and HF hospitalization, which are maintained over time. There were no differences between groups in mortality.
Funding Acknowledgement
Type of funding source: Public hospital(s). Main funding source(s): Hospital Universitari de Bellvitge
Collapse
Affiliation(s)
- L Alcoberro
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - J Vime
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - C Enjuanes
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - S Jimenez
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - A Garay
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - S Yun
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - P Moliner
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - C Guerrero
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - C Hidalgo
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - E Calero
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - R Marin
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| | - L Alcober
- Delta Primary Care Service, ICS, Hospitalet de Llobregat, Spain
| | - C Delso
- Delta Primary Care Service, ICS, Hospitalet de Llobregat, Spain
| | - J Comin
- University Hospital of Bellvitge, Hospitalet De Llobregat, Spain
| |
Collapse
|
14
|
Pearson CR, Kaysen D, Huh D, Bedard-Gillgan M, Walker D, Marin R, Saluskin K. A randomized comparison trial of culturally adapted HIV prevention approaches for Native Americans reducing trauma symptoms versus substance misuse: The Healing Seasons protocol. Contemp Clin Trials 2020; 95:106070. [PMID: 32561467 DOI: 10.1016/j.cct.2020.106070] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2020] [Revised: 05/27/2020] [Accepted: 06/12/2020] [Indexed: 11/28/2022]
Abstract
Native Americans (NA) experience interrelated risks of trauma exposure, substance use, and HIV risk behaviors that put them at increased risk for HIV infection. Despite these known risk factors, there are very few published randomized trials testing interventions to reduce trauma-related symptoms and substance misuse among NA. METHODS The Healing Seasons study is a randomized comparsion trial of two counseling strategies, Narrative Exposure Therapy (NET) addressing PTSD or Motivational interviewing with cognitive behavioral therapy skills training (MIST) addressing substance misuse as a means to prevent HIV among NA. Using a community-based participatory research approach, we adapted both evidence-based interventions to be specific to the risk contexts and realities of NA and to include psychoeducational and skill-building components that include cultural-specific stories, virtues, and traditional treatment strategies. Participants, 16 years and older, were recruited from a Pacific Northwest tribal community, screened over the phone, enrolled in person, and randomized in equal numbers to NET or MIST. We stratified by age (16-29 years and 30 or older) and gender (male or female identified) to ensure balance between treatment arms. The primary outcomes were number of sex partners and frequency of sexual acts (with and without condoms), sex under the influence of substances, frequency of substance use, and PTSD severity. DISCUSSION Behavioral interventions for NA are needed to prevent HIV risk behaviors when faced with trauma symptoms and substance misuse. This study will provide evidence to determine feasibility and efficacy of addressing related risk factors as part of counseling-based HIV prevention intervention to reduce sexual risk among this population. TRIAL REGISTRATION ClinicalTrials.gov number, NCT03112369, registered April 12, 2017.
Collapse
Affiliation(s)
- C R Pearson
- Indigenous Wellness Research Institute, School of Social Work, University of Washington, Seattle, WA, USA.
| | - D Kaysen
- Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
| | - D Huh
- Indigenous Wellness Research Institute, School of Social Work, University of Washington, Seattle, WA, USA
| | - M Bedard-Gillgan
- Department of Psychiatry, University of Washington, Seattle, WA, USA
| | - D Walker
- Innovative Programs Research Group, School of Social Work, University of Washington, Seattle, WA, USA
| | - R Marin
- Indigenous Wellness Research Institute, School of Social Work, University of Washington, Seattle, WA, USA
| | - K Saluskin
- Yakama Nation Behavioral Health Services, Toppenish, WA, USA
| |
Collapse
|
15
|
Sartore G, Chilelli NC, Seraglia R, Ragazzi E, Marin R, Roverso M, Cosma C, Vaccaro O, Burlina S, Lapolla A. Long-term effect of pioglitazone vs glimepiride on lipoprotein oxidation in patients with type 2 diabetes: a prospective randomized study. Acta Diabetol 2019; 56:505-513. [PMID: 30740640 DOI: 10.1007/s00592-018-01278-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/13/2018] [Accepted: 12/14/2018] [Indexed: 01/07/2023]
Abstract
AIMS Type 2 diabetes (DM2) is associated to oxidative modifications of high-density lipoproteins (HDL), which can interfere with their function. Pioglitazone has proved effective in raising HDL cholesterol (HDL-C) and lowering small dense low-density lipoprotein (LDL), but no clinical studies have examined its effect on lipoprotein oxidation in patients with DM2. METHODS We assessed the effect of pioglitazone vs glimepiride after 1 year on HDL oxidation, expressed as relative abundance of peptides containing Met112O in ApoA-I (oxApoA-I) estimated by mass spectrometry (MALDI/TOF/TOF), in 95 patients with DM2. The oxLDL and AGE were quantified by ELISA. RESULTS Patients receiving pioglitazone showed a significant increase in the concentration of ApoA-I (Δ = 7.2 ± 14.8 mg/dL, p < 0.02) and a reduction in oxApoA-I (Δ = - 1.0 ± 2.6%, p < 0.02); this reduction was not significantly different from glimepiride. oxLDL showed a slight, but not significant increase in both treatment groups. Regression analysis showed a correlation between ΔoxApoA-I and ΔAGE (r = 0.30; p = 0.007) in all patients, while both of these parameters were unrelated to changes in HbA1c, HDL-C, duration of illness, or use of statins. CONCLUSIONS Long-term treatment with pioglitazone was effective in reducing the oxidation of HDL, but not LDL in patients with DM2, while glimepiride didn't. This finding seems to be associated to the change of glyco-oxidation status, not to any improvement in glycemic control or lipid profile. TRIAL REGISTRATION NCT00700856, ClinicalTrials.gov Registered June 18, 2008.
Collapse
Affiliation(s)
- Giovanni Sartore
- Diabetology and Dietetics, Department of Medicine (DIMED), University of Padova, via Giustiniani, 2, 35100, Padua, Italy
| | - Nino Cristiano Chilelli
- Diabetology and Dietetics, Department of Medicine (DIMED), University of Padova, via Giustiniani, 2, 35100, Padua, Italy.
| | - Roberta Seraglia
- National Research Council-Institute for Energy and Interphases, Padua, Italy
| | - Eugenio Ragazzi
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy
| | - Raffaella Marin
- Lipid Laboratory, Department of Medicine (DIMED), University of Padova, Padua, Italy
| | - Marco Roverso
- National Research Council-Institute for Energy and Interphases, Padua, Italy
| | - Chiara Cosma
- Department of Laboratory Medicine, University of Padova, Padua, Italy
| | - Olga Vaccaro
- Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy
| | - Silvia Burlina
- Diabetology and Dietetics, Department of Medicine (DIMED), University of Padova, via Giustiniani, 2, 35100, Padua, Italy
| | - Annunziata Lapolla
- Diabetology and Dietetics, Department of Medicine (DIMED), University of Padova, via Giustiniani, 2, 35100, Padua, Italy
| |
Collapse
|
16
|
Biolo M, Scarinzi P, Bigolin P, Panzavolta C, Antonucci A, Marin R, Vianello D, Pagin J, Bertocco S, Gessoni G, Bariga AB, Manzato E, Zambon S, Fabris F, Zambon A. Plasma phospholipid fatty acid composition, lipid oxidation and inflammatory parameters in fishermen on diet rich in Northern Adriatic seafood. Atherosclerosis 2017. [DOI: 10.1016/j.atherosclerosis.2017.06.539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Skripka A, Benayas A, Marin R, Canton P, Hemmer E, Vetrone F. Double rare-earth nanothermometer in aqueous media: opening the third optical transparency window to temperature sensing. Nanoscale 2017; 9:3079-3085. [PMID: 28252155 DOI: 10.1039/c6nr08472a] [Citation(s) in RCA: 64] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
Owing to the alluring possibility of contactless temperature probing with microscopic spatial resolution, photoluminescence nanothermometry at the nanoscale is rapidly advancing towards its successful application in biomedical sciences. The emergence of near-infrared nanothermometers has paved the way for temperature sensing at the deep tissue level. However, water dispersibility, adequate size at the nanoscale, and the capability to efficiently operate in the second and third biological optical transparency windows are the requirements that still have to be fulfilled in a single nanoprobe. In this work, these requirements are addressed by rare-earth doped nanoparticles with core/shell-architecture, dispersed in water, whose excitation and emission wavelengths conveniently fall within the biological optical transparency windows. Under heating-free 800 nm excitation, double nanothermometry is realized either with Ho3+-Nd3+ (1.18-1.34 μm) or Er3+-Nd3+ (1.55-1.34 μm) NIR emission band ratios, both displaying equal thermal sensitivities around 1.1% °C-1. It is further demonstrated that, along with the interionic energy transfer processes, the thermometric properties of these nanoparticles are also governed by the temperature dependent energy transfer to the surrounding solvent (water) molecules. Overall, this work presents a novel water dispersible double ratiometric nanothermometer operating in the second and third biological optical transparency windows. The temperature dependent particle-solvent interaction is also presented, which is critical for e.g. future in vivo applications.
Collapse
Affiliation(s)
- A Skripka
- Institut National de la Recherche Scientifique, Centre Énergie Matériaux Télécommunications, Université du Québec, Varennes, Québec J3X 1S2, Canada.
| | - A Benayas
- Institut National de la Recherche Scientifique, Centre Énergie Matériaux Télécommunications, Université du Québec, Varennes, Québec J3X 1S2, Canada.
| | - R Marin
- Institut National de la Recherche Scientifique, Centre Énergie Matériaux Télécommunications, Université du Québec, Varennes, Québec J3X 1S2, Canada. and Dipartimento di Scienze Molecolari e Nanosistemi, Università Ca' Foscari di Venezia, Via Torino 155/b, I-30170, Venezia-Mestre, Italy
| | - P Canton
- Dipartimento di Scienze Molecolari e Nanosistemi, Università Ca' Foscari di Venezia, Via Torino 155/b, I-30170, Venezia-Mestre, Italy
| | - E Hemmer
- Institut National de la Recherche Scientifique, Centre Énergie Matériaux Télécommunications, Université du Québec, Varennes, Québec J3X 1S2, Canada.
| | - F Vetrone
- Institut National de la Recherche Scientifique, Centre Énergie Matériaux Télécommunications, Université du Québec, Varennes, Québec J3X 1S2, Canada. and Centre for Self-Assembled Chemical Structures, McGill University, Montréal, Québec H3A 2K6, Canada
| |
Collapse
|
18
|
Skripka A, Marin R, Benayas A, Canton P, Hemmer E, Vetrone F. Covering the optical spectrum through collective rare-earth doping of NaGdF4 nanoparticles: 806 and 980 nm excitation routes. Phys Chem Chem Phys 2017; 19:11825-11834. [DOI: 10.1039/c7cp01167a] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Sensitization of numerous emission bands (from ultraviolet to near-infrared) in rare-earth doped multilayered nanoparticles: 806 versus 980 nm excitation.
Collapse
Affiliation(s)
- A. Skripka
- Institut National de la Recherche Scientifique
- Centre Énergie Matériaux Télécommunication
- Université du Québec
- Varennes
- Canada
| | - R. Marin
- Institut National de la Recherche Scientifique
- Centre Énergie Matériaux Télécommunication
- Université du Québec
- Varennes
- Canada
| | - A. Benayas
- Institut National de la Recherche Scientifique
- Centre Énergie Matériaux Télécommunication
- Université du Québec
- Varennes
- Canada
| | - P. Canton
- Dipartimento di Scienze Molecolari e Nanosistemi
- Università Ca' Foscari di Venezia
- Via Torino 155/b
- I-30170
- Venezia-Mestre
| | - E. Hemmer
- Institut National de la Recherche Scientifique
- Centre Énergie Matériaux Télécommunication
- Université du Québec
- Varennes
- Canada
| | - F. Vetrone
- Institut National de la Recherche Scientifique
- Centre Énergie Matériaux Télécommunication
- Université du Québec
- Varennes
- Canada
| |
Collapse
|
19
|
Burlina S, Dalfrà MG, Barison A, Marin R, Ragazzi E, Sartore G, Lapolla A. Plasma phospholipid fatty acid composition and desaturase activity in women with gestational diabetes mellitus before and after delivery. Acta Diabetol 2017; 54:45-51. [PMID: 27638302 DOI: 10.1007/s00592-016-0901-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2016] [Accepted: 08/10/2016] [Indexed: 12/01/2022]
Abstract
AIMS Analyze plasma phospholipid fatty acids (PPFA) composition and desaturase activity in women with gestational diabetes (GDM) and in women with a normal glucose tolerance (NGT) before and after delivery, and to evaluate the possible relationship between desaturase activity and inflammatory parameters. METHODS PPFA composition was analyzed by gas chromatography in 21 women with GDM and from 21 with NGT, during the third trimester of pregnancy and 6 months after delivery. We used fatty acid product-to-precursor ratios to estimate desaturase activity, and we also measured in all women interleukins six and ten, tumor necrosis factor alpha and C-reactive protein. RESULTS No significant differences were observed between NGT and GDM women in terms of PPFA composition, both in pregnancy and after pregnancy. Estimated desaturase Δ9-18 activity was significantly higher, and estimated desaturase Δ5 activity was significantly lower during pregnancy in all women. We observed no correlations between inflammatory markers and desaturases activity, during or after pregnancy, in both groups. CONCLUSIONS Our data suggest that GDM does not influence PPFA composition and desaturase activity during pregnancy. In addition, late pregnancy characterized by hyperinsulinemia appears to upregulate desaturase Δ9-18 activity in NGT and GDM women.
Collapse
Affiliation(s)
- S Burlina
- Department of Medicine - DIMED, University of Padova, Via Giustiniani 2, 35100, Padua, Italy
| | - M G Dalfrà
- Department of Medicine - DIMED, University of Padova, Via Giustiniani 2, 35100, Padua, Italy
| | - A Barison
- Department of Medicine - DIMED, University of Padova, Via Giustiniani 2, 35100, Padua, Italy
| | - R Marin
- Department of Medicine - DIMED, University of Padova, Via Giustiniani 2, 35100, Padua, Italy
| | - E Ragazzi
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy
| | - G Sartore
- Department of Medicine - DIMED, University of Padova, Via Giustiniani 2, 35100, Padua, Italy.
| | - A Lapolla
- Department of Medicine - DIMED, University of Padova, Via Giustiniani 2, 35100, Padua, Italy
| |
Collapse
|
20
|
Bertin R, Chen Z, Marin R, Donati M, Feltrinelli A, Montopoli M, Zambon S, Manzato E, Froldi G. Activity of myricetin and other plant-derived polyhydroxyl compounds in human LDL and human vascular endothelial cells against oxidative stress. Biomed Pharmacother 2016; 82:472-8. [PMID: 27470387 DOI: 10.1016/j.biopha.2016.05.019] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2016] [Revised: 05/11/2016] [Accepted: 05/12/2016] [Indexed: 12/22/2022] Open
Abstract
Studies indicate that oxidative modifications of endothelium and LDL play a preeminent role in atherogenesis; therefore, the preservation of the endothelial antioxidant capacity and the inhibition of LDL oxidation by use of plant-derived compounds are an appealing strategy against several vascular disorders. On this basis, baicalein, eupatorin, galangin, magnolol, myricetin, oleuropein, silibinin and bilobalide were studied against various oxidative conditions. The radical scavenging capacity was analysed using DPPH and ORAC assays. Furthermore, the LDL oxidation was detected by measuring the formation of thiobarbituric acid reactive substances (TBARS) and by monitoring the oxidation kinetics. Further, we used cultured HUVEC to investigate the activities of the polyhydroxyl compounds towards the oxidative stress induced by H2O2. The lowest levels of TBARS were observed in the presence of oleuropein and baicalein, while myricetin, magnolol and eupatorin inhibited these ones to a lesser extent. In addition, oleuropein and myricetin exhibited higher protection in copper-induced LDL oxidation kinetics. However, only myricetin and galangin showed significant protective effects against H2O2 oxidative injury in HUVEC cells. Taken all together the results indicate myricetin as the most active agent among the selected plant-derived polyhydroxyl compounds, with prominent capacities against ox-LDL and ROS production in HUVEC.
Collapse
Affiliation(s)
- Riccardo Bertin
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo E. Meneghetti 2, 35131 Padova, Italy
| | - Zheng Chen
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo E. Meneghetti 2, 35131 Padova, Italy
| | - Raffaella Marin
- Department of Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
| | - Maddalena Donati
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo E. Meneghetti 2, 35131 Padova, Italy
| | - Angela Feltrinelli
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo E. Meneghetti 2, 35131 Padova, Italy
| | - Monica Montopoli
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo E. Meneghetti 2, 35131 Padova, Italy
| | - Sabina Zambon
- Department of Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
| | - Enzo Manzato
- Department of Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
| | - Guglielmina Froldi
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo E. Meneghetti 2, 35131 Padova, Italy.
| |
Collapse
|
21
|
Yamahara K, Demir-Hilton E, Preston C, Marin R, Pargett D, Roman B, Jensen S, Birch J, Boehm A, Scholin C. Simultaneous monitoring of faecal indicators and harmful algae using an in-situ
autonomous sensor. Lett Appl Microbiol 2015; 61:130-8. [DOI: 10.1111/lam.12432] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2015] [Revised: 04/16/2015] [Accepted: 04/18/2015] [Indexed: 11/29/2022]
Affiliation(s)
- K.M. Yamahara
- Center for Ocean Solutions; Stanford University; Stanford CA USA
- Monterey Bay Aquarium Research Institute; Moss Landing CA USA
| | - E. Demir-Hilton
- Monterey Bay Aquarium Research Institute; Moss Landing CA USA
| | - C.M. Preston
- Monterey Bay Aquarium Research Institute; Moss Landing CA USA
| | - R. Marin
- Monterey Bay Aquarium Research Institute; Moss Landing CA USA
| | - D. Pargett
- Monterey Bay Aquarium Research Institute; Moss Landing CA USA
| | - B. Roman
- Monterey Bay Aquarium Research Institute; Moss Landing CA USA
| | - S. Jensen
- Monterey Bay Aquarium Research Institute; Moss Landing CA USA
| | - J.M. Birch
- Monterey Bay Aquarium Research Institute; Moss Landing CA USA
| | - A.B. Boehm
- Environment and Water Studies; Stanford University; Stanford CA USA
| | - C.A. Scholin
- Monterey Bay Aquarium Research Institute; Moss Landing CA USA
| |
Collapse
|
22
|
Sartore G, Seraglia R, Burlina S, Bolis A, Marin R, Manzato E, Ragazzi E, Traldi P, Lapolla A. High-density lipoprotein oxidation in type 2 diabetic patients and young patients with premature myocardial infarction. Nutr Metab Cardiovasc Dis 2015; 25:418-425. [PMID: 25636381 DOI: 10.1016/j.numecd.2014.12.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/10/2014] [Revised: 12/10/2014] [Accepted: 12/12/2014] [Indexed: 11/22/2022]
Abstract
BACKGROUND AND AIMS ApoA-I can undergo oxidative changes that reduce anti-atherogenic role of HDL. The aim of this study was to seek any significant differences in methionine sulfoxide (MetO) content in the ApoA-I of HDL isolated from young patients with coronary heart disease (CHD), type 2 diabetics and healthy subjects. METHODS AND RESULTS We evaluated the lipid profile of 21 type 2 diabetic patients, 23 young patients with premature MI and 21 healthy volunteers; we determined in all patients the MetO content of ApoA-I in by MALDI/TOF/TOF technique. The typical MALDI spectra of the tryptic digest obtained from HDL plasma fractions all patients showed a relative abundance of peptides containing Met(112)O in ApoA-I in type 2 diabetic and CHD patients. This relative abundance is given as percentages of oxidized ApoA-I (OxApoA-I). OxApoA-I showed no significant correlations with lipoproteins in all patients studied, while a strong correlation emerged between the duration of diabetic disease and OxApoA-I levels in type 2 diabetic patients. CONCLUSIONS The most remarkable finding of our study lies in the evidence it produced of an increased HDL oxidation in patients highly susceptible to CHD. Levels of MetO residues in plasma ApoA-I, measured using an accurate, specific method, should be investigated and considered in prospective future studies to assess their role in CHD.
Collapse
Affiliation(s)
- G Sartore
- Department of Medicine - DIMED, University of Padova, Italy
| | | | - S Burlina
- Department of Medicine - DIMED, University of Padova, Italy.
| | - A Bolis
- Department of Medicine - DIMED, University of Padova, Italy
| | - R Marin
- Department of Medicine - DIMED, University of Padova, Italy
| | - E Manzato
- Department of Medicine - DIMED, University of Padova, Italy
| | - E Ragazzi
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Italy
| | | | - A Lapolla
- Department of Medicine - DIMED, University of Padova, Italy
| |
Collapse
|
23
|
Fernandez-Echevarria C, Díaz M, Ferrer I, Canerina-Amaro A, Marin R. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease. Neuroscience 2014; 278:354-66. [PMID: 25168729 DOI: 10.1016/j.neuroscience.2014.07.079] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2014] [Revised: 07/23/2014] [Accepted: 07/24/2014] [Indexed: 11/25/2022]
Abstract
Voltage-dependent anion channel (VDAC) is a mitochondrial protein abundantly found in neuronal lipid rafts. In these membrane domains, VDAC is associated with a complex of signaling proteins that trigger neuroprotective responses. Loss of lipid raft integrity may result in disruption of multicomplex association and alteration of signaling responses that may ultimately promote VDAC activation. Some data have demonstrated that VDAC at the neuronal membrane may be involved in the mechanisms of amyloid beta (Aβ)-induced neurotoxicity, through yet unknown mechanisms. Aβ is generated from amyloid precursor protein (APP), and is released to the extracellular space where it may undergo self-aggregation. Aβ aggregate deposition in the form of senile plaques may lead to Alzheimer's disease (AD) neuropathology, although other pathological hallmarks (such as hyper-phosphorylated Tau deposition) also participate in this neurodegenerative process. The present study demonstrates that VDAC1 associates with APP and Aβ in lipid rafts of neurons. Interaction of VDAC1 with APP was observed in lipid rafts from the frontal and entorhinal cortex of human brains affected by AD at early stages (I-IV/0-B of Braak and Braak). Furthermore, Aβ exposure enhanced the dephosphorylation of VDAC1 that correlated with cell death. Both effects were reverted in the presence of tyrosine phosphatase inhibitors. VDAC1 dephosphorylation was corroborated in lipid rafts of AD brains. These results demonstrate that Aβ is involved in alterations of the phosphorylation state of VDAC in neuronal lipid rafts. Modulation of this channel may contribute to the development and progression of AD pathology.
Collapse
Affiliation(s)
- C Fernandez-Echevarria
- Laboratory of Cellular Neurobiology, Department of Physiology, University of La Laguna, School of Medicine, Sta. Cruz de Tenerife, Spain
| | - M Díaz
- Laboratory of Membrane Physiology and Biophysics, Department of Animal Biology, Faculty of Biology, University of La Laguna, Sta. Cruz de Tenerife, Spain
| | - I Ferrer
- Institute of Neuropathology, Bellvitge University Hospital, University of Barcelona, IDIBELL, CIBERNED, Hospitalet de Llobregat, Barcelona, Spain
| | - A Canerina-Amaro
- Laboratory of Cellular Neurobiology, Department of Physiology, University of La Laguna, School of Medicine, Sta. Cruz de Tenerife, Spain
| | - R Marin
- Laboratory of Cellular Neurobiology, Department of Physiology, University of La Laguna, School of Medicine, Sta. Cruz de Tenerife, Spain.
| |
Collapse
|
24
|
Pellegrini M, Pallottini V, Marin R, Marino M. Role of the Sex Hormone Estrogen in the Prevention of Lipid Disorder. Curr Med Chem 2014; 21:2734-42. [DOI: 10.2174/0929867321666140303123602] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2013] [Revised: 10/30/2013] [Accepted: 10/31/2013] [Indexed: 11/22/2022]
|
25
|
Marin R, Casañas V, Pérez JA, Fabelo N, Fernandez CE, Diaz M. Oestrogens as modulators of neuronal signalosomes and brain lipid homeostasis related to protection against neurodegeneration. J Neuroendocrinol 2013; 25:1104-15. [PMID: 23795744 DOI: 10.1111/jne.12068] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/27/2013] [Revised: 05/22/2013] [Accepted: 06/18/2013] [Indexed: 12/19/2022]
Abstract
Oestrogens trigger several pathways at the plasma membrane that exert beneficial actions against neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Part of these actions takes place in lipid rafts, which are membrane domains with a singular protein and lipid composition. These microdomains also represent a preferential site for signalling protein complexes, or signalosomes. A plausible hypothesis is that the dynamic interaction of signalosomes with different extracellular ligands may be at the basis of neuronal maintenance against different neuropathologies. Oestrogen receptors are localised in neuronal lipid rafts, taking part of macromolecular complexes together with a voltage-dependent anion channel (VDAC), and other molecules. Oestradiol binding to its receptor at this level enhances neuroprotection against amyloid-β degeneration through the activation of different signal transduction pathways, including VDAC gating modulation. Moreover, part of the stability and functionality of signalling platforms lays on the distribution of lipid hallmarks in these microstructures, which modulate membrane physicochemical properties, thus favouring molecular interactions. Interestingly, recent findings indicate a potential role of oestrogens in the preservation of neuronal membrane physiology related to lipid homeostasis. Thus, oestrogens and docosahexaenoic acid may act synergistically to stabilise brain lipid structure by regulating neuronal lipid biosynthetic pathways, suggesting that part of the neuroprotective effects elicited by oestrogens occur through mechanisms aimed at preserving lipid homeostasis. Overall, oestrogen mechanisms of neuroprotection may occur not only by its interaction with neuronal protein targets through nongenomic and genomic mechanisms, but also through its participation in membrane architecture stabilisation via 'lipostatic' mechanisms.
Collapse
Affiliation(s)
- R Marin
- Department of Physiology, Laboratory of Cellular Neurobiology, University of La Laguna, La Laguna, Tenerife, Spain
| | | | | | | | | | | |
Collapse
|
26
|
Seraglia R, Sartore G, Marin R, Burlina S, Manzato E, Ragazzi E, Traldi P, Lapolla A. An effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients. J Mass Spectrom 2013; 48:105-110. [PMID: 23303753 DOI: 10.1002/jms.3113] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/18/2012] [Revised: 09/07/2012] [Accepted: 09/26/2012] [Indexed: 06/01/2023]
Abstract
Increased oxidation of low density lipoprotein (LDL) is characteristic of atherosclerosis. In this frame, high density lipoproteins (HDL) play an important role, being able to remove lipid peroxides (LPOs) and cholesterol from oxidized LDL, so exhibiting a protective role against atherosclerosis. A wide range of reactive compounds lead to the oxidation of methionine (Met) residues with the formation of methionine sulphoxide (MetO) in apolipoprotein A-I (ApoA-I). Consequently, the determination of MetO level can give both an evaluation of oxidative stress and the reduced capability of ApoA-I in LPOs and cholesterol transport. For these reasons, the development of analytical methods able to determine the MetO level is surely of interest, and we report here the results obtained by MALDI mass spectrometry.
Collapse
|
27
|
Knapik J, Spiess A, Grier T, Sharp M, Lester M, Marin R, Jones B. Injuries before and after deployments to Afghanistan and Iraq. Public Health 2012; 126:498-506. [DOI: 10.1016/j.puhe.2012.01.031] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2010] [Revised: 08/30/2011] [Accepted: 01/24/2012] [Indexed: 11/29/2022]
|
28
|
Carlino D, Leone E, Di Cola F, Baj G, Marin R, Dinelli G, Tongiorgi E, De Vanna M. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia. J Psychiatr Res 2011; 45:273-9. [PMID: 20630543 DOI: 10.1016/j.jpsychires.2010.06.012] [Citation(s) in RCA: 84] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/19/2009] [Revised: 05/12/2010] [Accepted: 06/17/2010] [Indexed: 11/17/2022]
Abstract
Brain-derived neurotrophic factor (BDNF) is a key factor in learning and memory. Altered BDNF-signalling is thought to contribute to the pathogenesis of schizophrenia (SZ) especially in relation to cognitive deficits. However, analysis of serum BDNF as a potential biomarker in schizophrenia has provided controversial data. We hypothesized that these confounding results might be due to a differential regulation of BDNF precursor pro-BDNF (32 KDa) and proteolytic products mature (mat-BDNF; 14 KDa), and truncated-BDNF (28 KDa). Accordingly, we investigated the serum abundance of these BDNF isoforms and its relationship with cognitive impairment in schizophrenia. Schizophrenia was diagnosed with PANSS test. Abbreviated cognitive assessment included tests for attention, perceptual-motor skills, processing speed and memory. Using an ELISA assay, we found a slight reduction in serum BDNF levels in SZ patients (n = 40) with respect to healthy controls (HC, n = 40; p = 0.018). Western-blot analysis revealed increased serum pro-BDNF and mat-BDNF and reduced truncated-BDNF (p < 0.001) in SZ with respect to HC. Patients with an increase in pro-BDNF (n = 15/40) or mat-BDNF (n = 9/40) higher than the HC mean + 2 Standard Deviations (SD) also had >2SD reduction of truncated-BDNF (n = 27/40). Reduced truncated-BDNF correlated significantly with higher positive and lower negative PANNS scores and a worst performance in all cognitive assays but not with antipsychotic type. Measurement of serum truncated-BDNF abundance predicted for high cognitive deficits with sensitivity = 67.5%, specificity = 97.5%, Negative Predictive Value = 75% and Positive Predictive Value = 96.4%. These results suggest deficiency in pro-BDNF processing as a possible biological mechanism underlying schizophrenia with cognitive impairment.
Collapse
Affiliation(s)
- Davide Carlino
- Dipartimento Clinico di Scienze Mediche, Tecnologiche e Traslazionali, Unita' Clinica Operativa di Clinica Psichiatrica, University of Trieste, Italy
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Lapolla A, Manzato E, Sartore G, Marin R, Cosma C, Bolis A, Seraglia R, Traldi P. Evaluation of methionine sulphoxide content of ApoA-I in type 2 diabetic patients and young coronaropathic subjects: a preliminary study. Rapid Commun Mass Spectrom 2011; 25:391-394. [PMID: 21192035 DOI: 10.1002/rcm.4861] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
|
30
|
Juarez JM, Campos M, Morales A, Palma J, Marin R. Applications of Temporal Reasoning to Intensive Care Units. Journal of Healthcare Engineering 2010. [DOI: 10.1260/2040-2295.1.4.615] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
31
|
Romanato G, Scarpa M, Angriman I, Faggian D, Ruffolo C, Marin R, Zambon S, Basato S, Zanoni S, Filosa T, Pilon F, Manzato E. Plasma lipids and inflammation in active inflammatory bowel diseases. Aliment Pharmacol Ther 2009; 29:298-307. [PMID: 19035968 DOI: 10.1111/j.1365-2036.2008.03886.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/08/2022]
Abstract
BACKGROUND Ulcerative colitis (UC) and Crohn's disease (CD) can cause metabolic and inflammatory alterations. AIM To evaluate the relationships between inflammatory parameters, plasma lipids and phospholipid fatty acid (FA) composition in patients with active UC and CD. METHODS Diet, the Harvey-Bradshaw Activity Index (HBAI), inflammatory parameters, lipoproteins and FA composition were assessed in 60 CD and 34 UC. RESULTS No differences in clinical parameters were observed in the two groups. Total cholesterol correlated inversely with the number of bowel movements in both groups and directly with BMI in UC. Arachidonic acid correlated inversely with HBAI in UC and total and HDL cholesterol were inversely related to C-reactive protein (CRP) in CD while HDL correlated with CRP in UC. Docosapentaenoic acid was the only polyunsaturated n-3 FA that was correlated to CRP in both groups. Total cholesterol was independently associated in the multiple regression analysis with the number of bowel movements and systemic inflammation. CONCLUSIONS Total and LDL cholesterol were lower in the active UC and CD than in the healthy subjects and were correlated with the systemic inflammatory status. Phospholipid FA composition was correlated to the systemic inflammatory status, but was unrelated to dietary intake and intestinal disease activity.
Collapse
Affiliation(s)
- G Romanato
- CNR-Institute of Neurosciences-Aging Section, Padova, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Stojakovic M, Stojakovic B, Pandzic V, Vukadinovic S, Subotic M, Martinovic M, Marin R. Depression in War-related Post Traumatic Stress Disorder and the Enduring Personality Change After Catastrophic Experience (F62.0) a 15-year Follow-up. Eur Psychiatry 2009. [DOI: 10.1016/s0924-9338(09)71503-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Objective:This study was a 15-year follow-up examination. Many patients with F 62.0 and post traumatic stress disorder (PTSD) have symptoms of depression. The authors’ objective is to analyze symptoms of depression in F 62.0 and PTSD.Method:The subjects were 200 male psychiatric patients at a Clinic of psychiatry medical center Banjaluka and psychiatry department of with war-related PTSD. Post traumatic stress syndrom-PTSS scale and 21-item Hamilton Rating Scale for Depression-HAMD was used to assess state measures of symptom severity; from 3 months to 15 years after returning from the war.Results:The symptoms of prolonged PTSS (with duration between six moths and two years) had been founded at 54%, and 32% of patients had no diagnosis PTSD. The enduring personality change after catastrophic experience (F 62.0) had been found at 14% patients (with duration more than two years), 19% met HAMD Diagnostic Criteria for major depressive disorder.The enduring personality exchange F 62.0 had been found at 8% patients and 16% met HAMD Diagnostic Criteria for major depressive disorder 15 years after returning from the war.Conclusions:The statistical relationship between level of combat exposure and PTSD symptoms at 15 years, suggests that it may take time for the consequences of traumatic exposure to become apparent. Moreover, degree of exposure may be important in predicting the eventual development of symptoms and precipitation of F 62.0 enduring personality exchange. Continued follow-up will address the evolution of PTSD symptoms in war related PTSD.
Collapse
|
33
|
Sartore G, Lapolla A, Reitano R, Zambon S, Romanato G, Marin R, Cosma C, Manzato E, Fedele D. Desaturase activities and metabolic control in type 2 diabetes. Prostaglandins Leukot Essent Fatty Acids 2008; 79:55-8. [PMID: 18771908 DOI: 10.1016/j.plefa.2008.07.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/28/2008] [Revised: 06/27/2008] [Accepted: 07/11/2008] [Indexed: 10/21/2022]
Abstract
The aim of this study was to elucidate the effects of a poor glycemic control on fatty acid composition and desaturase activities in type 2 diabetic patients. Plasma phospholipid fatty acid composition and desaturase activities (estimated from fatty acid product to precursor ratios) were measured in 30 type 2 diabetic patients during poor metabolic control and after achieving a good metabolic control. Significant changes were recorded in the percentages of palmitic, stearic, dihomo-gamma-linolenic, docosatetraenoic and docosapentaenoic acid. The delta-5 desaturase activity was significantly higher with poor than with good metabolic control. The changes identified in plasma phospholipid fatty acid composition and the desaturase activity in type 2 diabetic patients go in the opposite direction to those described in similar conditions in type 1 diabetic patients and may be relevant to a better understanding of the role of metabolic control in the progression of chronic complications in type 2 diabetic patients.
Collapse
Affiliation(s)
- G Sartore
- Department of Medical and Surgical Sciences, University of Padua, Via Dei Colli, 4, 35143 Padova, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Scarpa M, Romanato G, Manzato E, Ruffolo C, Marin R, Basato S, Zambon S, Filosa T, Zanoni S, Pilon F, Polese L, Sturniolo GC, D'Amico DF, Angriman I. Restorative proctocolectomy for ulcerative colitis: impact on lipid metabolism and adipose tissue and serum fatty acids. J Gastrointest Surg 2008; 12:279-87. [PMID: 17955308 DOI: 10.1007/s11605-007-0380-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/17/2007] [Accepted: 09/26/2007] [Indexed: 01/31/2023]
Abstract
The aim of this prospective study was to evaluate the changes of the metabolism of circulating and storage lipids in patients with ulcerative colitis after restorative proctocolectomy. Fifteen consecutive patients and 15 sex- and age-matched healthy controls were enrolled. Disease activity, diet, inflammatory parameters, plasma lipoprotein concentrations, and fatty acids (FA) of serum phospholipids and of the subcutaneous adipose tissue were assessed at colectomy and at ileostomy closure. In ulcerative colitis patients, total cholesterol and docosahexaenoic acid were lower than in healthy subjects (p < 0.01 and p < 0.05). The median interval between colectomy and ileostomy closure was 6 (range 2-9) months. During that interval, the inflammatory parameters improved, high-density lipoproteins (HDL) cholesterol increased (p < 0.01), and low-density (LDL) cholesterol decreased (p = 0.01). At ileostomy closure, serum arachidonic acid levels were increased (p = 0.04), whereas serum oleic acid level was decreased (p = 0.02). In this interval, no significant alteration, either in serum n-3 FA precursors or in the FA of subcutaneous adipose tissue, was observed. The increase of serum arachidonic acid after colectomy might suggest a lower utilization for inflammatory process. The reduction of LDL cholesterol is an index of malabsorption probably due to the accelerated transit and to the exclusion of the terminal ileum caused by the covering ileostomy.
Collapse
Affiliation(s)
- Marco Scarpa
- Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Policlinico Universitario, University of Padova, Padova, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Manzato E, Romanato G, Zambon S, Corti MC, Baggio G, Sartori L, Musacchio E, Zanoni S, Marin R, Crepaldi G. Metabolic syndrome and cardiovascular disease in the elderly: the Progetto Veneto Anziani (Pro.V.A.) study. Aging Clin Exp Res 2008; 20:47-52. [PMID: 18283228 DOI: 10.1007/bf03324747] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
BACKGROUND AND AIMS The prevalence of the metabolic syndrome increases with age, although only few data are available about its prevalence in the general elderly population. This study describes the prevalence of the metabolic syndrome in an elderly population, and its association with cardiovascular diseases. METHODS The Progetto Veneto Anziani (Pro.V.A.) is an observational study of 3,099 subjects aged 65 and older, randomly selected from the general population of Northern Italy. Cardiovascular diseases and metabolic syndrome according to Adult Treatment Panel III were evaluated in 2,910 subjects. RESULTS The metabolic syndrome was present in 25.6% of men and 48.1% of women. Its prevalence was mainly due to high blood pressure (93%) in both sexes, and to abdominal obesity in 73% of women. The prevalence of cardiovascular diseases was significantly higher among subjects with metabolic syndrome. Together with age and former smoking habits, the metabolic syndrome was significantly associated with cardiovascular diseases. High blood pressure and low HDL were independently associated with cardiovascular diseases in men, and with high fasting plasma glucose and waist circumference in women. CONCLUSIONS The metabolic syndrome is frequent, and significantly but not independently associated with prevalent cardiovascular diseases in the elderly. In old people, rather than the metabolic syndrome per se, some of its components are independently associated with cardiovascular diseases.
Collapse
Affiliation(s)
- Enzo Manzato
- Department of Medical and Surgical Sciences, University of Padova, 35128 Padova, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Marin R, Bugarin A, Santos Reyes J, Onaindía E. Resumen de la XI Conferencia de la Asociacion Española para la Inteligencia Artificial (CAEPIA 2005). Int Artif 2007. [DOI: 10.4114/ia.v10i30.950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
37
|
Abstract
Electronic pedometers were used to quantify locomotor physical activity during an entire 9-week United States Army Basic Combat Training (BCT) cycle. Pedometers were worn on the hips of 4 trainees in each of 10 BCT companies during all BCT activities. Investigators obtained pedometer readings (steps) on a daily basis, and estimated travel distances were obtained by multiplying steps by the average individual step length. A short questionnaire was administered daily to assure trainees wore the pedometers and trained with their companies all day. Trainees performed an average +/- SD of 16 311 +/- 5826 steps/day and traveled an estimated 11.7 +/- 4.4 kilometers/day. The highest daily locomotor activity was during the field training exercise in which trainees took an average +/- SD of 22 372 +/- 12 517 steps/day traveling an estimated 16.2 +/- 9.7 kilometers/day. Differences among the 10 companies ranged from 14 720 +/- 6649 steps/day to 18 729 +/- 6328 steps/day. This survey provided the first examination of locomotor physical activity during an entire BCT cycle.
Collapse
Affiliation(s)
- J J Knapik
- U. S. Army Center for Health Promotion and Preventive Medicine, Aberdeen Proving Ground, MD 21010, USA.
| | | | | | | | | | | |
Collapse
|
38
|
Marin R, Onaindía E. Introduction to the special issue. Int Artif 2006. [DOI: 10.4114/ia.v10i31.932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
39
|
Lapolla A, Sartore G, Della Rovere GR, Romanato G, Zambon S, Marin R, Manzato E, Fedele D. Plasma fatty acids and lipoproteins in type 2 diabetic patients. Diabetes Metab Res Rev 2006; 22:226-31. [PMID: 16308886 DOI: 10.1002/dmrr.607] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND The dyslipidemia of type 2 diabetic patients is characterized by high VLDL, abnormal LDL composition and low HDL cholesterol concentrations. The aim of this study was to establish whether the type of dietary fats affects LDL size and density and HDL cholesterol concentrations in these patients. METHODS Plasma phospholipid fatty acid composition, which reflects the type of dietary fatty acids, was quantified by gas chromatography. LDL relative flotation (LDL-Rf), a measure of LDL particle size and density, was determined by single vertical spin density gradient ultracentrifugation in 97 type 2 diabetic patients. RESULTS By linear regression analysis of the data, plasma fatty acids were associated neither with LDL-cholesterol levels nor with LDL-Rf. The HDL cholesterol concentrations were negatively related with saturated fatty acids (r = -0.23; p = 0.02) but positively related with monounsaturated fatty acids (r = +0.20; p = 0.00). Furthermore, higher HDL concentrations were associated with large and buoyant LDL particles (HDL cholesterol vs LDL-Rf: r = +0.47; p = 0.00). In the multiple regression analysis, the LDL-Rf was significantly related both to triglycerides (beta coefficient = -0.55, p = 0.000) and HDL cholesterol (beta coefficient = 0.19, p = 0.034) concentrations. In a stepwise regression analysis including both triglycerides and HDL cholesterol, triglycerides alone explained the 43.0% of the LDL-Rf variability. CONCLUSIONS A reduction of the dietary saturated fats and an increment of monounsaturated fats might increase HDL cholesterol concentrations in type 2 diabetic patients. Modifications of LDL composition might be expected from interventions aimed to reduce plasma triglycerides.
Collapse
Affiliation(s)
- Annunziata Lapolla
- Department of Medical and Surgical Sciences, University of Padova, Italy
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Di Mario F, Aragona G, Dal Bó N, Cavallaro L, Marcon V, Olivieri P, Benedetti E, Orzès N, Marin R, Tafner G, Chilovi F, De Bastiani R, Fedrizzi F, Franceschi M, Salvat MH, Monica F, Piazzi L, Valiante F, Vecchiati U, Cavestro GM, Comparato G, Iori V, Maino M, Leandro G, Pilotto A, Rugge M, Franzè A. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. Aliment Pharmacol Ther 2006; 23:1235-40. [PMID: 16611285 DOI: 10.1111/j.1365-2036.2006.02851.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
BACKGROUND Cure rates for eradication of Helicobacter pylori appear to be decreasing, thus more effective therapies must be identified. AIM To evaluate the efficacy of bovine lactoferrin in the treatment of H. pylori infection. METHODS In a multicentered prospective study, 402 (mean age 52.4, range 19-84 years) H. pylori-positive patients were assigned to one of three regimens: group A - esomeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d. for 7 days; group B - lactoferrin 200 mg b.d. for 7 days followed by the same schedule of group A; group C - esomeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d. plus lactoferrin 200 mg b.d. for 7 days. RESULTS Of the 402 patients, 389 completed the study. Six patients were discontinued due to side effects, one patient in group B died and six patients were lost to follow up. The eradication rate (intention-to-treat analysis) was 77% in group A (105/136), 73% in group B (97/132) and 90% in group C (120/134) (chi(2)-test P < 0.01). The incidence of side effects was 9.5% in group A, 9% in group B and 8.2% in group C (chi(2)-test P = 0.1). CONCLUSION This study demonstrates that bovine lactoferrin is an effective adjuvant to 7-day triple therapy for eradication of H. pylori infection.
Collapse
Affiliation(s)
- F Di Mario
- Gastroenterology, University of Parma, Parma, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Piarulli F, Lapolla A, Sartore G, Laverda B, Reitano R, Marin R, Manzato E, Fedele D. We-P11:22 Carotid atherosclerotic plaques in type 2 diabetic patients: Role of glycoxidation. ATHEROSCLEROSIS SUPP 2006. [DOI: 10.1016/s1567-5688(06)81378-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
42
|
Tim teo A, Oliveira M, Antunes E, Feliciano J, Marin R, Coito S, Marques F, Quininha J. 220 Head-up tilt testing potentiated with a low-dose sublingual nitroglycerine in elderly patients with unexplained syncope. Europace 2005. [DOI: 10.1016/eupace/7.supplement_1.44-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Affiliation(s)
- A. Tim teo
- Hospital Santa Marta, Cardiology Dept., Lisbon, Portugal
| | - M.J.M. Oliveira
- Hospital Santa Marta, Department of Cardiology, Lisbon, Portugal
| | - E. Antunes
- Hospital Santa Marta, Cardiology Dept., Lisbon, Portugal
| | - J. Feliciano
- Hospital Santa Marta, Cardiology Dept., Lisbon, Portugal
| | - R. Marin
- Hospital Santa Marta, Cardiology Dept., Lisbon, Portugal
| | - S. Coito
- Hospital Santa Marta, Cardiology Dept., Lisbon, Portugal
| | - F. Marques
- Hospital Santa Marta, Cardiology Dept., Lisbon, Portugal
| | - J. Quininha
- Hospital Santa Marta, Cardiology Dept., Lisbon, Portugal
| |
Collapse
|
43
|
Hieber W, Schulten H, Marin R. Über Metallcarbonyle. XXVIII. Hochdrucksynthese von Kobaltcarbonyl und Kobaltcarbonylwasserstoff aus Kobaltverbindungen. ACTA ACUST UNITED AC 2004. [DOI: 10.1002/zaac.19392400306] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
44
|
González Bouchon J, González Mathiesen I, González Galvez M, Marin R, Varas A, Montesinos TMM. Trabéculo-sclérectomie non perforante avec mitomycine C, sans implant. J Fr Ophtalmol 2004; 27:907-11. [PMID: 15547472 DOI: 10.1016/s0181-5512(04)96235-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
PURPOSE Since 1998 we have been conducting a prospective study of nonpenetrating deep trabeculectomy with chronic open-angle glaucoma to evaluate the efficiency of the technique. MATERIAL AND METHODS The study was carried out in 55 eyes of 41 patients who suffered from open-angle glaucoma. After performing a superior scleral flap, mitomycin diluted to 0.01% was applied for 3 minutes, then the 4 x 4-mm superficial scleral flap was dissected at two-thirds deepness until reaching the cornea. The Schlemm canal and the external trabecula were surgically removed and the two points of the Schlemm canal were catheterized with a trabeculotome to ensure that the ablation was well done. If it was not, it was completed by using a trabeculotome as a guide. Postoperatively, if the filtering bleb tended to decrease or ocular pressure began to increase, the operated trabecular region was reopened with Yag laser. The filtering bleb characteristics were correlated with the normalization of intraocular pressure in the first 30 cases. RESULTS Preoperative pressure without treatment was 32 mmHg. Postoperative intraocular pressure without treatment was 20 mmHg or less in 79% of the eyes after 4 months, 77.5% after 6 months, 75% after 8 months and 61% after 12 months. By adding a local hypotension treatment in monotherapy, a pressure of 20 mmHg or less was obtained in 79% of the cases after 12 months. No severe complications were observed. The presence of a filtering bleb is an important factor in the normalization of postoperative pressure (p=0.0048). CONCLUSIONS This surgical technique provides a substantial decrease in intraocular pressure and very few complications after 12 months of follow-up.
Collapse
|
45
|
Alvarez de Sotomayor M, Perez-Guerrero C, Herrera M, Marin R, Jimenez L, Marhuenda E, Andriantsitohaina R. M.439 Pleiotropic effects of simvastin on endothelial dysfunction from aged rats: Role of no and cyclo-oxygenase products. ATHEROSCLEROSIS SUPP 2004. [DOI: 10.1016/s1567-5688(04)90438-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
46
|
Marin R, Guerra B, Morales A, Diaz M, Alonso R. An ICI 182,780-sensitive, membrane-related estrogen receptor contributes to estrogenic neuroprotective actions against amyloid-beta toxicity. Ann N Y Acad Sci 2004; 1007:108-16. [PMID: 14993045 DOI: 10.1196/annals.1286.011] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Although estrogen (E2)-related neuroprotection has been repeatedly demonstrated in different models, the involvement of non-classical estrogen receptors (ERs) in this activity remains unclear. Using SN56 murine cholinergic cell line from the basal forebrain, we present evidence indicating that an ER associated with the plasma membrane participates in estrogen-dependent reduction of neuronal death induced by amyloid-beta peptide (Abeta) toxicity. Exposure to either E2 or estradiol-horseradish peroxidase (E-HRP) for 15 min significantly reduced Abeta-induced cell death. This effect was decreased by the ER antagonist ICI 182,780 as well as by MC-20 antibody directed to a region neighboring the ligand-binding domain of ERa. Using MC-20 antibody in unpermeabilized SN56 cells, we detected a protein at the plasma membrane region. The binding of impermeant forms of E2, E-HRP, and E-BSA-FITC to specific sites of SN56 plasma membrane was blocked by pre-incubation with E2, ICI 182,780, and MC-20 antibody in a concentration-dependent manner. Thus, a membrane-related ER that shares some structural homologies with ERalpha may participate in estrogen-mediated neuroprotection.
Collapse
Affiliation(s)
- R Marin
- Laboratory of Cellular Neurobiology, Department of Physiology, University of La Laguna, School of Medicine, 38071 Sta. Cruz de Tenerife, Spain.
| | | | | | | | | |
Collapse
|
47
|
Marin R, Guerra B, Hernández-Jiménez JG, Kang XL, Fraser JD, López FJ, Alonso R. Estradiol prevents amyloid-beta peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptor. Neuroscience 2004; 121:917-26. [PMID: 14580942 DOI: 10.1016/s0306-4522(03)00464-0] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
The pathology of Alzheimer's disease includes amyloid-beta peptide aggregation that contributes to degeneration of cholinergic neurons. Even though the underlying molecular mechanisms remain unclear, recent in vitro evidence supports a protective role for estrogens against several neurotoxic agents. Here we report that, in a murine cholinergic cell line (SN56), the massive cell death induced by 1-40 fragment of amyloid-beta peptide was prevented by 17beta-estradiol through a mechanism that may involve estrogen receptor activation. The protective effect of estradiol was observed in a dose-dependent manner, and was completely blocked by the pure antiestrogen ICI 182,780. In contrast, the inactive isomer 17alpha-estradiol consistently showed weaker neuroprotection than the native hormone that was unaffected by ICI 182,780 treatment. In addition, equivalent concentrations of 17beta-estradiol enhanced luciferase activity in cells transfected with a luciferase reporter gene driven by tandem estrogen response elements. Estrogen-induced luciferase activity was blocked by ICI 182,780, indicating estrogen receptor-dependent transcriptional activity. We also observed by reverse transcription-polymerase chain reaction, Western blot and immunocytochemistry that increasing concentrations of 17beta-estradiol enhanced the expression of estrogen receptor alpha mRNA and protein during amyloid-beta-induced toxicity. Under these conditions, it was found by confocal microscopy that the localization of estrogen receptor alpha in the absence of hormone was mainly extranuclear. However, the receptor was consistently observed also at the nuclear region after estrogen exposure. Overall, these data suggest that estrogen may exert neuroprotective effects against amyloid-beta-induced toxicity by activation of estrogen receptor-mediated pathways. In addition, intracellular estrogen receptors are up-regulated by their cognate hormone even during exposure to neurotoxic agents.
Collapse
Affiliation(s)
- R Marin
- Laboratory of Cellular Neurobiology, Department of Physiology, University of La Laguna, School of Medicine, 38071 Santa Cruz de Tenerife, Spain
| | | | | | | | | | | | | |
Collapse
|
48
|
|
49
|
Abstract
Estrogen exerts a neuroprotective action in response to a variety of cell stresses. However, to what extent intracellular estrogen receptors are involved in these functions remains to be determined. We have found that SN56 cells, a neuronal-derived cholinergic cell line which produces luteinizing hormone-releasing hormone and contains the mRNAs encoding estrogen and progesterone receptors, also express estrogen receptor alpha, as well as the heat shock protein 90. Exposure of these cells to drastic temperature elevation for 1 h immediately increased the intracellular levels of these two proteins, whereas it rapidly reduced the content of estrogen receptor alpha mRNA. In addition, the amount of estrogen receptor alpha-heat shock protein 90 complexes was increased in response to thermal stress. Pre-treatment with geldanamycin, a potent inhibitor of heat shock protein 90, decreased the amount of estrogen receptor alpha, suggesting that its elevation after the heat insult may be related to its association with heat shock protein 90. In contrast, exposure of heat-shocked cells to 17beta-estradiol reduced the number of estrogen receptor alpha-heat shock protein 90 complexes, suggesting that the receptor conserves the affinity for its cognate ligand under these conditions. Therefore, the interaction of the estrogen receptor with heat shock protein 90 may serve to prevent its degradation during the thermal insult, as well as to maintain it in a high-affinity hormone-binding conformation. Since neuroprotective estrogen effects have been described in a variety of cytotoxic situations, these findings may be suggestive of an integrated neuronal response to injury, which includes the protection of available estrogen receptors through their association with heat shock protein 90.
Collapse
Affiliation(s)
- R Marin
- Laboratory of Cellular Neurobiology, Department of Physiology, University of La Laguna School of Medicine, 38071, Sta Cruz de Tenerife, Spain
| | | | | |
Collapse
|
50
|
Abstract
OBJECTIVE To investigate in a random comparison the capacity of an angiotensin converting enzyme inhibitor (fosinopril), and that of a long-acting dihydropiridine (nifedipine GITS) to modify the decay in renal function in patients with primary renal disease, exhibiting a progressive increase in serum creatinine during the previous 2 years. METHODS A randomized, open-label, multicenter study with a minimum follow-up of 3 years. A total of 241 patients were included in the study. All of them were hypertensive and had a 25% or at least 0.5 mg/dl increase in the value of serum creatinine during the 24 months prior to entering the study. Initial doses of fosinopril and nifedipine GITS were 10 and 30 mg respectively, and titration to 30 and 60 mg was performed if needed to obtain the expected blood pressure goal (< 140/90 mmHg). Furosemide, atenolol, and doxazosin were added as second, third, and fourth drugs if necessary, for blood pressure control. The primary end-point of the study was the appearance of double the serum creatinine values and/or the need to enter a dialysis programme. Secondary end-points were cardiovascular events, death, changes in 24 h proteinuria, and the evolution of serum creatinine. Data reflect the analysis performed by intention to treat. RESULTS Mean age of the group was 54 +/- 14, and 59% were males. Primary glomerulonephritis (31%), nephrosclerosis (26%) and polycystic kidney disease (19%) were the three most frequent diagnostic findings. After 3 years of follow-up, 21% (27/127) of patients treated with fosinopril, and 36% (40/112) of those receiving nifedipine GITS presented a primary end-point, (OR 0.47, 95% confidence intervals 0.26-0.84, P = 0.01). Renal survival was significantly better when fosinopril constituted the first step therapy (P = 0.002). These results did not seem to be influenced by the type of primary renal disease. Proteinuria decreased at the end of the study by a mean of 57% in the fosinopril group and increased by 7% in the group receiving dihydropiridine. Blood pressure control did not differ among groups for diastolic values. During follow-up, however, the patients receiving ACEi showed systolic blood pressure values 4-6 mmHg lower. CONCLUSION In patients with chronic renal failure and hypertension due to primary renal disease, fosinopril significantly differed from nifedipine GITS by its capacity to slow the progressive decay in renal function. The drugs also differed by their capacity to lower blood pressure. The better control, in particular of systolic blood pressure, in the fosinopril arm could have contributed in a relevant manner to the attainment of a better outcome when the ACEi was employed.
Collapse
Affiliation(s)
- R Marin
- Servicio de Nefrología, Hospital Covadonga, Oviedo, Spain.
| | | | | | | | | | | |
Collapse
|